These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17885687)

  • 1. Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease.
    Cho SR; Benraiss A; Chmielnicki E; Samdani A; Economides A; Goldman SA
    J Clin Invest; 2007 Oct; 117(10):2889-902. PubMed ID: 17885687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain.
    Benraiss A; Chmielnicki E; Lerner K; Roh D; Goldman SA
    J Neurosci; 2001 Sep; 21(17):6718-31. PubMed ID: 11517261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirally expressed noggin and brain-derived neurotrophic factor cooperate to induce new medium spiny neurons from resident progenitor cells in the adult striatal ventricular zone.
    Chmielnicki E; Benraiss A; Economides AN; Goldman SA
    J Neurosci; 2004 Mar; 24(9):2133-42. PubMed ID: 14999064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF.
    Benraiss A; Bruel-Jungerman E; Lu G; Economides AN; Davidson B; Goldman SA
    Gene Ther; 2012 May; 19(5):483-93. PubMed ID: 21918547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of striatal neurogenesis enhances functional recovery in an adult animal model of neonatal hypoxic-ischemic brain injury.
    Im SH; Yu JH; Park ES; Lee JE; Kim HO; Park KI; Kim GW; Park CI; Cho SR
    Neuroscience; 2010 Aug; 169(1):259-68. PubMed ID: 20610036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
    Popovic N; Maingay M; Kirik D; Brundin P
    Exp Neurol; 2005 May; 193(1):65-74. PubMed ID: 15817265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse.
    Smail S; Bahga D; McDole B; Guthrie K
    Chem Senses; 2016 Mar; 41(3):221-32. PubMed ID: 26783111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment.
    Kells AP; Henry RA; Connor B
    Gene Ther; 2008 Jul; 15(13):966-77. PubMed ID: 18323792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington's disease.
    Benraiss A; Toner MJ; Xu Q; Bruel-Jungerman E; Rogers EH; Wang F; Economides AN; Davidson BL; Kageyama R; Nedergaard M; Goldman SA
    Cell Stem Cell; 2013 Jun; 12(6):787-99. PubMed ID: 23746982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.
    Rebec GV; Conroy SK; Barton SJ
    Neuroscience; 2006; 137(1):327-36. PubMed ID: 16257492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
    Cepeda C; Starling AJ; Wu N; Nguyen OK; Uzgil B; Soda T; André VM; Ariano MA; Levine MS
    J Neurosci Res; 2004 Dec; 78(6):855-67. PubMed ID: 15505789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease.
    Jin K; LaFevre-Bernt M; Sun Y; Chen S; Gafni J; Crippen D; Logvinova A; Ross CA; Greenberg DA; Ellerby LM
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18189-94. PubMed ID: 16326808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment.
    Lazic SE; Grote HE; Blakemore C; Hannan AJ; van Dellen A; Phillips W; Barker RA
    Eur J Neurosci; 2006 Apr; 23(7):1829-38. PubMed ID: 16623840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.
    Conforti P; Ramos C; Apostol BL; Simmons DA; Nguyen HP; Riess O; Thompson LM; Zuccato C; Cattaneo E
    Mol Cell Neurosci; 2008 Sep; 39(1):1-7. PubMed ID: 18571429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical characterization of newly generated neurons in the striatum of adult primates.
    Bédard A; Gravel C; Parent A
    Exp Brain Res; 2006 Apr; 170(4):501-12. PubMed ID: 16328260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.
    Traficante A; Riozzi B; Cannella M; Rampello L; Squitieri F; Battaglia G
    Neuroreport; 2007 Dec; 18(18):1997-2000. PubMed ID: 18007201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor gene transfer with adeno-associated viral and lentiviral vectors prevents rubrospinal neuronal atrophy and stimulates regeneration-associated gene expression after acute cervical spinal cord injury.
    Kwon BK; Liu J; Lam C; Plunet W; Oschipok LW; Hauswirth W; Di Polo A; Blesch A; Tetzlaff W
    Spine (Phila Pa 1976); 2007 May; 32(11):1164-73. PubMed ID: 17495772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowed progression in models of Huntington disease by adipose stem cell transplantation.
    Lee ST; Chu K; Jung KH; Im WS; Park JE; Lim HC; Won CH; Shin SH; Lee SK; Kim M; Roh JK
    Ann Neurol; 2009 Nov; 66(5):671-81. PubMed ID: 19938161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.